Biotechnology Viking Therapeutics’ Weight Loss Study Data Outperformed Novo Nordisk, Eli Lilly Studies, Analysts Say – Viking Therapeutics (NASDAQ:VKTX) Read more
Biotechnology Obesity Solutions Like Weight Loss Drugs To Act As Catalyst For Economic Surge, Goldman Sachs Forecasts – Novo Nordisk (NYSE:NVO) Read more
Biotechnology Global Access to Weight-Loss Treatments: Indian Pharma Giants Eye Affordable Wegovy Alternatives Amid Rising Demand – Novo Nordisk (NYSE:NVO) Read more
Biotechnology Novo Nordisk’s Weight Loss Drugs Ozempic, Wegovy Show Promise For Diabetic Patients Undergoing Hip Replacement – Novo Nordisk (NYSE:NVO) Read more
Biotechnology Novo Nordisk, Eli Lilly Stride To Boost Supply Shortage For Newly Found Holy Grail Of Miraculous Weight Loss Drugs – Novo Nordisk (NYSE:NVO), Eli Lilly (NYSE:LLY) Read more
Opinion Thinking about trading options or stock in Tesla, Microsoft, Novo Nordisk, Intel, or Solaredge Technologies? – Microsoft (NASDAQ:MSFT), Intel (NASDAQ:INTC) Read more
Biotechnology The Skinny On Novo Nordisk: Weight-Loss Meds Make Big Pharma A Big Foe For Food Industry – Catalent (NYSE:CTLT), Chipotle Mexican Grill (NYSE:CMG) Read more
Stockmarkets Catalent stock downgraded post Novo Nordisk acquisition deal By biedexmarkets.com Read more
Stockmarkets US FDA finds control lapses at Catalent plant being sold to Novo Reuters via biedexmarkets.com Read more
Biotechnology Ozempic Maker Strikes $11B Deal With Catalent As It Rushes To Meet Massive Weight-Loss Drug Demand – Catalent (NYSE:CTLT), Novo Nordisk (NYSE:NVO) Read more